735 related articles for article (PubMed ID: 27410431)
21. Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI).
Ngwa JS; Fungwe TV; Ntekim O; Allard JS; Johnson SM; Castor C; Graham L; Nadarajah S; Gillum RF; Obisesan TO;
Dement Geriatr Cogn Disord; 2018; 45(1-2):66-78. PubMed ID: 29694964
[TBL] [Abstract][Full Text] [Related]
22. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
[TBL] [Abstract][Full Text] [Related]
23. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
Ren D; Lopez OL; Lingler JH; Conley Y
J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
[TBL] [Abstract][Full Text] [Related]
24. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
28. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H
Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.
Hostage CA; Roy Choudhury K; Doraiswamy PM; Petrella JR;
PLoS One; 2013; 8(2):e54483. PubMed ID: 23405083
[TBL] [Abstract][Full Text] [Related]
31. The relationship between APOE genotype, CSF Tau and cognition across the Alzheimer's disease spectrum, moderation and mediation role of insula network connectivity.
Zhu Y; Wu Y; Lv X; Wu J; Shen C; Tang Q; Wang G;
CNS Neurosci Ther; 2024 Jan; 30(1):e14401. PubMed ID: 37577852
[TBL] [Abstract][Full Text] [Related]
32. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
34. Impact of APOE in mild cognitive impairment.
Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
[TBL] [Abstract][Full Text] [Related]
35. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
[TBL] [Abstract][Full Text] [Related]
36. APOE ε4 positivity predicts centrality of episodic memory nodes in patients with mild cognitive impairment: A cohort-based, graph theory-informed study of cognitive networks.
De Marco M; Wright LM; Valera Bermejo JM; Ferguson CE
Neuropsychologia; 2024 Jan; 192():108741. PubMed ID: 38040087
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of the APOE genotype on brain function across the lifespan.
Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE
Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan.
Wang PN; Lirng JF; Lin KN; Chang FC; Liu HC
Neurobiol Aging; 2006 Dec; 27(12):1797-806. PubMed ID: 16321457
[TBL] [Abstract][Full Text] [Related]
39. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms.
Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M
Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143
[TBL] [Abstract][Full Text] [Related]
40. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
Polsinelli AJ; Logan PE; Lane KA; Manchella MK; Nemes S; Sanjay AB; Gao S; Apostolova LG
Alzheimers Dement; 2023 May; 19(5):1983-1993. PubMed ID: 36394443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
